Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MountainTap-5: BMS-986504 in MTAP-deleted advanced or metastatic solid tumors
CTR20262733Phase 2Active
- Sponsor
- Bristol Myers Squibb
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of navlimetostat in Nonhematologic neoplasms, sponsored by Bristol Myers Squibb. Started Aug 2026; status: active.
02
Drugs
navlimetostat
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on CTR20262733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262733.